

Igalmi costs $95-$105 per film without insurance. Learn how to save with coupons, discount cards, patient assistance programs, and insurance tips.
Igalmi (Dexmedetomidine sublingual film) is an effective treatment for acute agitation in adults with schizophrenia or bipolar disorder — but it comes with a significant price tag. With no generic version available, the cost can be a real barrier for patients and the facilities that treat them.
In this guide, we'll break down exactly how much Igalmi costs, and share every strategy we know for saving money on this medication in 2026.
Let's start with the numbers:
Because Igalmi is typically used for acute episodes (not daily maintenance), most patients will need only 1-3 films per treatment episode. However, even a single dose at nearly $100 is significant, especially for uninsured patients or facilities managing tight budgets.
Several prescription discount platforms offer savings on Igalmi:
Price: ~$104.69 for a single 180 mcg film
SingleCare offers a free coupon that can be used at participating pharmacies. While this may not always beat the cash price, it provides a consistent discount option. Visit singlecare.com/prescription/igalmi for current pricing.
While Igalmi's availability on discount platforms is limited due to its specialty nature, it's worth checking these resources:
Important note: Because Igalmi is administered in clinical settings rather than dispensed at retail pharmacies, coupon card utility may be limited. These tools work best when a facility's pharmacy can process a retail-style prescription.
If you're uninsured or underinsured, patient assistance programs (PAPs) may help reduce or eliminate the cost of Igalmi:
Contact the manufacturer directly for information about patient assistance:
BioXcel Therapeutics may offer programs to help eligible patients access Igalmi at reduced or no cost. Eligibility typically depends on income level and insurance status.
These organizations help connect patients with medication assistance programs:
Insurance coverage for Igalmi varies significantly:
If you're receiving Igalmi in a hospital or psychiatric facility, the cost may be bundled into your overall facility charges rather than billed as a separate medication. Ask your facility's billing department how Igalmi will be billed and whether your insurance covers it as part of the visit.
Many hospitals have charity care programs or financial assistance offices that can help reduce out-of-pocket costs for medications administered during your stay. Ask to speak with a financial counselor or social worker at the facility where you're being treated.
If you have a choice of where to receive treatment, costs can vary between facilities. Use Medfinder to find facilities that have Igalmi in stock, and ask about pricing before your visit when possible.
As of 2026, there is no generic version of Igalmi (Dexmedetomidine sublingual film). While generic IV Dexmedetomidine (Precedex) is available, the sublingual film formulation is patent-protected and exclusive to BioXcel Therapeutics. This means the brand-name price is the only option for this specific formulation.
If cost is prohibitive and you need treatment for acute agitation, talk to your provider about more affordable alternatives like generic Haloperidol or Lorazepam. See our alternatives to Igalmi guide for details.
At $95-$105 per film with no generic available, Igalmi can be expensive — but there are ways to reduce the financial burden. Start by contacting BioXcel Therapeutics for patient assistance, check your insurance benefits carefully, explore discount card options, and ask about financial assistance at your treatment facility.
Don't let cost prevent you from getting the treatment you need. Between manufacturer support, insurance advocacy, and the strategies above, there are pathways to make Igalmi more affordable.
More Igalmi resources:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.